Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

2026 data Public-data reference. official source

Musculoskeletal Injury

Open-data reference.

16 US clinical trials · 8 currently recruiting

Active & Recent Trials

RECRUITING 5,000 participants

Baseline ACL Injury Risk Screening and Normative Data

Sanford Health

NCT06635668

RECRUITING 1,218 participants

Quality of Life and Life Satisfaction in Pediatric and Adolescent Gymnasts Through Injury

University of Colorado, Denver

NCT05110729

RECRUITING 370 participants

Use of an Integrated Orthotic and Rehabilitation Initiative for Treatment of Lower Extremity Musculoskeletal Disorders

Wake Forest University Health Sciences

NCT05780502

RECRUITING Phase 4 200 participants

Can Immediate Post-injury Fluoxetine Improve the Recovery Trajectories of Victims in Bodily Trauma?

University of Florida

NCT06046859

RECRUITING 148 participants

Post-Concussion Musculoskeletal Injury Risks

Walter Reed National Military Medical Center

NCT05122728

RECRUITING Phase 4 120 participants

Adaptions and Resiliency to Multi-Stressor OpeRations

Bradley Nindl

NCT06455969

RECRUITING NA 40 participants

The Effects of AFO Heel Height and Stiffness on Gait

University of Iowa

NCT04800484

RECRUITING NA 30 participants

Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma

Johns Hopkins University

NCT05989230

ACTIVE NOT RECRUITING 181 participants

Micro-Doppler Radar: A Gold Standard Comparison

Milton S. Hershey Medical Center

NCT05521126

ACTIVE NOT RECRUITING NA 40 participants

Mind-Body Conditioning Course for University Dance Students

Ohio State University

NCT06925503

COMPLETED NA 150 participants

Use of a Self-Directed Exercise Program (SDEP) Following Selected Lower Extremity Fractures

Wake Forest University Health Sciences

NCT04612478

COMPLETED 135 participants

Real-World Experience of Patients Treated for Musculoskeletal Injuries With SAM in Routine Care

ZetrOZ

NCT05254470

COMPLETED NA 104 participants

The Impact of a mHealth Application on Outpatient Physical Therapy HEP Adherence and Outcomes: A RCT

Aultman Health Foundation

NCT03035682

COMPLETED NA 55 participants

A Skills-Based Program Delivered Via Secure Live Video to Patients With Acute Musculoskeletal Trauma

Massachusetts General Hospital

NCT03405610

COMPLETED NA 18 participants

Surgeon Core-strengthening Program as a Modifier for Exertion Associated With Vaginal Surgery

Loyola University

NCT06525701

COMPLETED Early Phase 1 18 participants

Feasibility of Near-infrared Spectroscopy to Measure Cortical Pain Pathway (Brain) Activation During Dry Needling

Army-Baylor University Doctoral Program in Physical Therapy

NCT04170803

Phase Distribution

PhaseTrial count
Early Phase 1 1
Phase 4 2

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Reading the Musculoskeletal Injury Trial Landscape

ClinicalTrials.gov lists 16 US studies indexed under Musculoskeletal Injury, and 8 of those are currently open to recruitment — roughly 50% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.

The phase distribution for Musculoskeletal Injury shows 2 late-stage studies (Phase 3 and Phase 4 combined) alongside 1 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.

Top sponsor activity for Musculoskeletal Injury is led by Wake Forest University Health Sciences with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 16 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.

Frequently Asked Questions

How many clinical trials are there for Musculoskeletal Injury?

PlainTrial tracks 16 US clinical trials for Musculoskeletal Injury, of which 8 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Musculoskeletal Injury?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →